OF
GILD icon

Optimize Financial’s Gilead Sciences GILD Stock Holding History

Optimize Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Sell
3,079
-664
-18% -$93K 0.21% 175
2025
Q4 		$459K Buy
3,743
+52
+1% +$6.32K 0.23% 167
2025
Q3 		$410K Buy
+3,691
New +$420K 0.21% 204

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Optimize Financial's GILD Position: Q1 2026 in Review

Optimize Financial reduced its Gilead Sciences (GILD) stake by 18% in Q1 2026, selling an estimated $93K and leaving 3,079 shares worth $429K. The position accounts for 0.21% of the portfolio, ranked #175.

Optimize Financial first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. The position peaked at $459K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Optimize Financial held 3,079 shares of Gilead Sciences worth $429K as of Q1 2026.
  • Optimize Financial sold 664 Gilead Sciences shares in Q1 2026, an estimated $93K.
  • Gilead Sciences made up 0.21% of Optimize Financial's portfolio in Q1 2026, its #175 holding.
  • Optimize Financial first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • Optimize Financial's Gilead Sciences position peaked at $459K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Optimize Financial's 13F filing for Q1 2026, filed 12 May 2026.